Published in Antimicrob Agents Chemother on June 01, 1982
The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus. J Virol (1995) 1.37
Chemotherapy of rhinovirus colds. Antimicrob Agents Chemother (1988) 1.30
Topical enviroxime against rhinovirus infection. Antimicrob Agents Chemother (1982) 0.97
Replication and Inhibitors of Enteroviruses and Parechoviruses. Viruses (2015) 0.89
Evaluation of an alpha agonist alone and in combination with a nonsteroidal antiinflammatory agent in the treatment of experimental rhinovirus colds. Bull N Y Acad Med (1989) 0.89
Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo. Antimicrob Agents Chemother (2013) 0.88
Controlled trial of enviroxime against natural rhinovirus infections in a community. Antimicrob Agents Chemother (1985) 0.88
Discovery of itraconazole with broad-spectrum in vitro antienterovirus activity that targets nonstructural protein 3A. Antimicrob Agents Chemother (2015) 0.86
Activity against rhinoviruses, toxicity, and delivery in aerosol of enviroxime in liposomes. Antimicrob Agents Chemother (1988) 0.83
Antirhinovirus activity of purine nucleoside analogs. Antimicrob Agents Chemother (1986) 0.80
Ipratropium bromide treatment of experimental rhinovirus infection. Antimicrob Agents Chemother (1988) 0.78
Immune modulation by aspirin during experimental rhinovirus colds. Bull N Y Acad Med (1989) 0.76
Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity. AMA Arch Intern Med (1958) 3.83
The activity of enviroxime against rhinovirus infection in man. Lancet (1981) 1.66
Inhibition of rhinovirus replication in in organ culture by a potential antiviral drug. J Infect Dis (1980) 1.66
Distribution and removal of human serum albumin-technetium 99m instilled intranasally. Br J Clin Pharmacol (1976) 1.52
Interruption of experimental rhinovirus transmission. J Infect Dis (1980) 1.47
A comparison of nasal and tracheobronchial clearance. Arch Environ Health (1974) 1.36
Improved method for collection of nasal mucus. J Infect Dis (1977) 1.31
Human nasal mucosal function in a controlled climate. Arch Environ Health (1971) 1.29
Social ties and susceptibility to the common cold. JAMA (1997) 7.08
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med (1998) 6.75
Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J (2001) 4.93
Influenza virus neuraminidase inhibitors. Lancet (2000) 4.89
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res (2002) 4.85
Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J Infect Dis (2001) 3.69
Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob Agents Chemother (1980) 3.60
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr (2000) 3.53
Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis (1975) 3.33
Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol (2003) 2.92
Position statement: global neuraminidase inhibitor susceptibility network. Antiviral Res (2001) 2.91
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis (2000) 2.90
Zoster sine herpete, a clinical variant. Ann Neurol (1994) 2.84
Transmission of rhinovirus colds by self-inoculation. N Engl J Med (1973) 2.80
Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses. Am J Respir Crit Care Med (1999) 2.76
A cloud adult: the Staphylococcus aureus-virus interaction revisited. Ann Intern Med (1996) 2.66
Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol (2001) 2.58
Sinusitis of the maxillary antrum. N Engl J Med (1975) 2.57
Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis (1997) 2.54
Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics. Antimicrob Agents Chemother (1983) 2.53
Successful treatment of naturally occurring influenza A/USSR/77 H1N1. JAMA (1981) 2.50
Types of stressors that increase susceptibility to the common cold in healthy adults. Health Psychol (1998) 2.47
Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants. Antimicrob Agents Chemother (2001) 2.46
Hand-to-hand transmission of rhinovirus colds. Ann Intern Med (1978) 2.46
Risk factors for acute wheezing in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens. Pediatrics (1993) 2.41
Rhinovirus infections in an industrial population. I. The occurrence of illness. N Engl J Med (1966) 2.27
Temperature-sensitive mutants of influenza A virus. XII. Safety, antigenicity, transmissibility, and efficacy of influenza A/Udorn/72-ts-1[E] recombinant viruses in human adults. J Infect Dis (1976) 2.12
A collaborative report: rhinoviruses--extension of the numbering system from 89 to 100. Virology (1987) 2.10
Frequency and natural history of rhinovirus infections in adults during autumn. J Clin Microbiol (1997) 2.09
Spread of Streptococcus pneumoniae in families. II. Relation of transfer of S. pneumoniae to incidence of colds and serum antibody. J Infect Dis (1975) 2.05
Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J Infect Dis (1999) 2.03
Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults. Antimicrob Agents Chemother (1981) 1.99
Performance of virus isolation and Directigen Flu A to detect influenza A virus in experimental human infection. J Clin Virol (1999) 1.98
Methods to improve detection of pneumococci in respiratory secretions. J Clin Microbiol (1975) 1.94
Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction. Pediatrics (1998) 1.94
Etiology of acute conjunctivitis in children. J Pediatr (1981) 1.92
In vitro susceptibility studies with josamycin and erythromycin. Antimicrob Agents Chemother (1976) 1.89
Effect of inhalation of hot humidified air on experimental rhinovirus infection. JAMA (1994) 1.87
Emergence of drug resistance during an influenza epidemic: insights from a mathematical model. J Infect Dis (1998) 1.85
Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. J Infect Dis (1995) 1.84
Picornavirus infections: a primer for the practitioner. Arch Fam Med (2000) 1.80
Alteration of cerebrospinal fluid findings by partial treatment of bacterial meningitis. J Pediatr (1973) 1.77
Detection of rhinovirus in sinus brushings of patients with acute community-acquired sinusitis by reverse transcription-PCR. J Clin Microbiol (1997) 1.76
Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections. Infect Dis Clin North Am (1987) 1.73
Rhinoviruses. Yale J Biol Med (1975) 1.66
Comparison of the Immulok cultureset kit and virus isolation for detection of herpes simplex virus in clinical specimens. J Clin Microbiol (1983) 1.64
Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines. Rev Infect Dis (1983) 1.64
Rapid diagnosis of lymphocytic meningitis by frequency-pulsed electron capture gas-liquid chromatography: differentiation of tuberculous, cryptococcal, and viral meningitis. J Clin Microbiol (1977) 1.63
Coronavirus infections in military recruits. Three-year study with coronavirus strains OC43 and 229E. Am Rev Respir Dis (1974) 1.62
Rapid diagnosis of influenza A and B by 24-h fluorescent focus assays. J Clin Microbiol (1988) 1.57
Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon. N Engl J Med (1986) 1.56
A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge. Am J Epidemiol (1971) 1.54
Etiology and antimicrobial therapy of acute maxillary sinusitis. J Infect Dis (1979) 1.52
Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection. Antimicrob Agents Chemother (1999) 1.49
Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrob Agents Chemother (1987) 1.49
Accuracy of Gram's stain in identifying pneumococci in sputum. JAMA (1978) 1.48
Interruption of experimental rhinovirus transmission. J Infect Dis (1980) 1.47
Hospital-acquired infections. I. Surveillance in a university hospital. Am J Epidemiol (1976) 1.47
Epidemiologic evidence for Lancefield group C beta-hemolytic streptococci as a cause of exudative pharyngitis in college students. J Clin Microbiol (1997) 1.45
Micro-neutralization test for identification of rhinovirus serotypes. Proc Soc Exp Biol Med (1966) 1.44
Kinins are generated during experimental rhinovirus colds. J Infect Dis (1988) 1.44
In vitro activity of zinc salts against human rhinoviruses. Antimicrob Agents Chemother (1987) 1.40
Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study. Clin Infect Dis (2000) 1.40
Detection of human rhinovirus RNA in nasal washings by PCR. Mol Cell Probes (1993) 1.39
New human adenovirus isolated from a renal transplant recipient: description and characterization of candiate adenovirus type 34. J Clin Microbiol (1975) 1.37
Rhinovirus infections in an industrial population. II. Characteristics of illness and antibody response. JAMA (1967) 1.33
Chemotherapy of rhinovirus colds. Antimicrob Agents Chemother (1988) 1.30
Sites of rhinovirus recovery after point inoculation of the upper airway. JAMA (1986) 1.30
Etiology and antimicrobial treatment of acute sinusitis. Ann Otol Rhinol Laryngol Suppl (1981) 1.30
Intranasal interferon alpha 2 for prevention of rhinovirus infection and illness. J Infect Dis (1983) 1.30
Rhinovirus inhibition by 3-substituted triazinoindoles. Proc Soc Exp Biol Med (1970) 1.29
Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults. Antimicrob Agents Chemother (1985) 1.29
Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. JAMA (1999) 1.28
Enhancement of activity against influenza viruses by combinations of antiviral agents. Antimicrob Agents Chemother (1980) 1.28
Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferrets. J Infect Dis (1991) 1.27
Activity of 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile (MDL-860) against picornaviruses in vitro. Antimicrob Agents Chemother (1982) 1.27
Enterovirus meningitis in adults. Clin Infect Dis (1998) 1.25
Coronavirus infections in working adults. Eight-year study with 229 E and OC 43. Am Rev Respir Dis (1972) 1.23
Swine-influenza infection in civilians. Report of two cases. N Engl J Med (1976) 1.23
Diagnosis of pneumococcal pneumonia by antigen detection in sputum. J Clin Microbiol (1978) 1.22
Rapid identification of pneumococci. Gram stain vs. the quellung reaction. N Engl J Med (1973) 1.21
Localization of human rhinovirus replication in the upper respiratory tract by in situ hybridization. J Infect Dis (1995) 1.21
Comparative susceptibilities of human embryonic fibroblasts and HeLa cells for isolation of human rhinoviruses. J Clin Microbiol (1996) 1.19
Transmission of experimental rhinovirus infection by contaminated surfaces. Am J Epidemiol (1982) 1.18
In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses. Antiviral Res (2000) 1.18
Alterations of the eustachian tube, middle ear, and nose in rhinovirus infection. Arch Otolaryngol Head Neck Surg (1989) 1.18
Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and control. J Infect Dis (1993) 1.17
Rhinovirus infections in an industrial population. IV. Infections within families of employees during two fall peaks of respiratory illness. Am J Epidemiol (1969) 1.17
Respiratory syncytial virus stimulation of vascular endothelial cell growth Factor/Vascular permeability factor. Am J Respir Cell Mol Biol (2000) 1.17
State and trait negative affect as predictors of objective and subjective symptoms of respiratory viral infections. J Pers Soc Psychol (1995) 1.17
Viral aggregation resulting in the failure to correctly identify an unknown rhinovirus. Appl Microbiol (1970) 1.16
Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. J Infect Dis (1994) 1.15
Histopathologic examination and enumeration of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinovirus colds. Acta Otolaryngol Suppl (1984) 1.14